“Genetic and Acquired Lipodystrophies: Decoding Human Metabolism Through Rare Disorders”

Speaker:

Abhimanyu Garg, M.D.
Professor of Internal Medicine
Division of Endocrinology
UT Southwestern Medical Center

About Abhimanyu Garg:

Originally from New Delhi, India, Dr. Garg received his medical degree and completed his residency in internal medicine at the All India Institute of Medical Sciences. He performed fellowships in endocrinology and metabolism at the University of Alabama at Birmingham and at UT Southwestern. He joined the faculty of UT Southwestern in 1988.

Dr. Garg is a leading expert worldwide on lipodystrophy treatment and research. He was the first researcher to test the hormone leptin as a treatment for lipodystrophy as part of a clinical trial that started at UT Southwestern in 2000. In 2014, the U.S. Food and Drug Administration approved the drug form of leptin for the treatment of generalized lipodystrophy.

His current research focuses on whether leptin therapy will improve metabolic complications in hypoleptinemic patients with partial lipodystrophies.